Skilarence 120mg, magensaftresistente Tablette - 180 Swissmedic Key 66703003 Registration Holder Almirall AG Name Skilarence 120mg, magensaftresistente Tablette Date of registration 28.01.2019 Introduction of Sequence 28.01.2019 ATC-Classification Dimethyl Fumarate (L04AX07) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 10.03. Show package size 180 Index Therapeuticus (Swissmedic) 10.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price 357.15 Deductible k.A. Consumer price 426.40 Feedback FB Daily cost GTIN 7680667030034 Medication Code Synthetika Pharmacode Disponibility
Composition dimethylis fumaras 120 mg, lactosum monohydricum 144 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, simeticonum, E 132, E 171, natrii hydroxidum, pro compresso obducto corresp. natrium 1.94 mg. Packungsbestandteile Galenic Form Gastric juice resistant tablets BAG: Active Agent Dose 120 mg
Inactive agents Dose additional_information Überzug color. color. Lactose Monohydrate 144 mg Sodium Hydroxide Polysorbatum 80 Silica Colloidalis Anhydrica Simeticone Talcum
Source Data was imported : 07.07.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
